Scientific publications

Molecular Psychiatry, 2025

The anti-NMDAR1 antibodies and IL-17 signaling pathway shape NMDAR encephalitis

Xu Z., Yan H., Wang B. et al.

Atherosclerosis, 2025

Identifying plasma proteomic biomarkers for risk prediction and therapeutic targets of abdominal aortic aneurysm: Prospective cohort and Mendelian randomization analyses

Zhang Y., Huang Y., Gan X. et al.

Brain, 2025

Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases

Lona-Durazo F., Byrne R., Pilon M. et al.

Advanced Science, 2025

A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk

Gan X., Wei Y., Wu Y. et al.

Scientific Reports, 2025

The moderating role of diet and physical activity in insulin resistance and immunometabolic depression

Gruber J., Schiweck C., Ruf A. et al.

Bioscience Reports, 2025

Serum proteomics mirrors the histopathological changes underlying different etiologies of primary mitral valve disease

Garcia-Peña A., Ibarrola J., Segur M. et al.

International Journal of Surgery, 2025

Plasma proteomic markers predict risk for bowel resection in inflammatory bowel disease: a retrospective cohort study

Xu X., Xu C., Zeng N. et al.

Journal of Inflammation Research, 2025

Development of Predictive Models for Long-Term Endoscopic Response to Ustekinumab in Crohn’s Disease Based on Plasma Proteomics

Wu C., Zheng J., Qian X. et al.

Journal of Thoracic Disease, 2025

Postoperative innate immune function after minimally invasive transcervical esophagectomy (MICE) versus minimally invasive transthoracic esophagectomy (MIE)

Jacobs L., Drager L., Joosten L. et al.

Critical Public Health, 2025

Causal relationships between plasma protein ratios and lung cancer risk: a Mendelian randomization study

Zhang P., Chen Y., Yao L. et al.

Journal for ImmunoTherapy of Cancer, 2025

Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer

Wang X., Ricciuti B., Elkrief A. et al.

JCI Insight, 2025

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis

Strawn D., Krueger J., Bissonnette R. et al.

Cytokine, 2025

Associations between plasma ANGPTL4 levels and the risk of 24 cancers: a prospective cohort study

Cheng X., Zhao S., Du M. et al.

Hepatology Research, 2025

Plasma Vascular Endothelial Growth Factor‐A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Tajima K., Miuma S., Sasaki R. et al.

Journal of the Endocrine Society, 2025

Urinary Proteomics as a Noninvasive Readout of Obesity-associated Inflammation

Canki E., Kho E., van Stiphout R. et al.

Cancer Immunology, Immunotherapy, 2025

Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Changoer P., Peng C., van Houten P. et al.

Pancreas, 2025

Plasma Proteomics Identifies Potential Pancreatic Cancer Risk Indicators in Type 2 Diabetes

Chu S., Liu J., Liu X. et al.

International Journal of Molecular Sciences, 2025

Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

González-Montero M., Andrés-Rodríguez J., Criado M. et al.

Inflammatory Bowel Diseases, 2025

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Ricciuto A., Turinsky A., Griffiths A. et al.

Circulation, 2025

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Hundertmark M., Birkhoelzer S., Portwood C. et al.